tiprankstipranks
Trending News
More News >

Jared Kelly Insider Profile

4 Followers
Jared Kelly, Chief Executive Officer at Oncolytics Biotech, holds 73.90K shares in Oncolytics Biotech (Ticker: ONCY). Most recently, Jared Kelly Bought 23,500 shares of Oncolytics Biotech on Aug 13, 2025 for an estimated value of $20.28K.
tipranks
Jared  Kelly

Jared Kelly
Oncolytics Biotech (ONCY)
Chief Executive Officer

Ranked #57,793 out of 103,431 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-6.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$78K
100.00%
A breakdown of Jared Kelly's holdings

Insider Roles

Oncolytics Biotech
(ONCY)
Chief Executive Officer
Roles that Jared Kelly holds in companies

Most Profitable Insider Trade

Stock:
Oncolytics Biotech
(ONCY)
Rating:Informative Buy
Date:Aug 13, 2025 - Today
Return:+3.90%
The most profitable trade made by Jared Kelly

Jared Kelly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncolytics Biotech
Aug 13, 2025
Chief Executive Officer
Informative Buy
20.28K
$78.33K
Success Rate for
ONCY
1 out of 2 profitable transactions on
ONCY
50%
Average Return for
ONCY
Average return per transaction on
ONCY
-6.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 18, 2025
Informative Buy
$60.06K
-
$1.19
-16.50%
Aug 13, 2025
Informative Buy
$20.28K
-
$0.86
+3.90%
List of latest transactions for each holding click on a transaction to see Jared Kelly's performance on stock

Jared Kelly insider profile FAQ

What is the percentage of profitable transactions made by Jared Kelly?
The percentage of profitable transactions made by Jared Kelly is 50%.
    What is the average return per transaction made by Jared Kelly?
    The average return per transaction made by Jared Kelly is -6.30%.
      What stocks does Jared Kelly hold?
      Jared Kelly holds: ONCY stocks.
        What was Jared Kelly’s latest transaction?
        Jared Kelly latest transaction was an Informative Buy of $20.28K.
          What was Jared Kelly's most profitable transaction?
          Jared Kelly’s most profitable transaction was an Informative Buy of ONCY stock on August 13, 2025. The return on the trade was 3.90%.
            What is Jared Kelly's role in Oncolytics Biotech?
            Jared Kelly's role in Oncolytics Biotech is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.